Mutual of America Capital Management’s Kura Oncology KURA Stock Holding History

Mutual of America Capital Management’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,000	Closed	-$20K	–	1691
2020 Q1	$20K	Hold	2,000	–	–	﹤0.01%	1493
2019 Q4	$28K	Hold	2,000	–	–	﹤0.01%	1502
2019 Q3	$30K	Sell	2,000 -1,000	-33%	-$17.8K	﹤0.01%	1470
2019 Q2	$59K	Hold	3,000	–	–	﹤0.01%	1300
2019 Q1	$50K	Hold	3,000	–	–	﹤0.01%	1282
2018 Q4	$42K	Buy	3,000 +500	+20%	+$6.63K	﹤0.01%	1273
2018 Q3	$44K	Sell	2,500 -1,000	-29%	-$19.2K	﹤0.01%	1270
2018 Q2	$64K	Hold	3,500	–	–	﹤0.01%	1190
2018 Q1	$66K	Hold	3,500	–	–	﹤0.01%	1172
2017 Q4	$54K	Sell	3,500 -1,500	-30%	-$22.1K	﹤0.01%	1185
2017 Q3	$75K	Buy	5,000 +2,500	+100%	+$23.5K	﹤0.01%	1173
2017 Q2	$23K	Buy	+2,500	New	+$22.8K	﹤0.01%	1206

Other funds holding KURA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Mutual of America Capital Management's KURA Position: Q2 2020 in Review

Mutual of America Capital Management sold out of Kura Oncology (KURA) in Q2 2020, closing a stake of 2,000 shares — an estimated $20K sold.

Mutual of America Capital Management first reported a position in KURA in Q2 2017 and held it in 12 quarters. The position peaked at $75K in Q3 2017. 134 funds tracked by Wall St. Rank hold KURA as of Q2 2020.

Mutual of America Capital Management reported no remaining Kura Oncology position as of Q2 2020 after selling out during the quarter.
Mutual of America Capital Management sold 2,000 Kura Oncology shares in Q2 2020, an estimated $20K.
Mutual of America Capital Management first reported a position in Kura Oncology in Q2 2017 and held it in 12 quarters.
Mutual of America Capital Management's Kura Oncology position peaked at $75K in Q3 2017.
134 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2020.

Based on Mutual of America Capital Management's 13F filing for Q2 2020, filed 6 Aug 2020.